The AST:ALT ratio was originally developed in 1957 to help identify the cause of hepatitis, in which a ratio ≥2.0 suggests ALD, and a reduced ratio indicates viral hepatitis.76 In patients with MASLD, the AST:ALT ratio is typically <0.8, reflecting a greater rise in ALT than AST. The gene discussed is GPT; the disease is animal viral hepatitis.